Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: Becton, Dickinson and Company

Capitalization 41.65B 36.07B 33.1B 31.14B 58B 3,969B 58.9B 393B 153B 1,919B 156B 153B 6,675B P/E ratio 2026 *
37.7x
P/E ratio 2027 * 28.8x
Enterprise value 57.61B 49.89B 45.77B 43.07B 80.21B 5,489B 81.47B 544B 212B 2,655B 216B 212B 9,232B EV / Sales 2026 *
3x
EV / Sales 2027 * 2.83x
Free-Float
74.04%
Yield 2026 *
2.55%
Yield 2027 * 2.6%
1 day-0.99%
1 week+2.61%
Current month+1.37%
1 month-0.20%
3 months-9.87%
6 months-21.30%
Current year-23.16%
1 week 143.13
Extreme 143.13
153.24
1 month 141.82
Extreme 141.8201
153.24
Current year 141.82
Extreme 141.8201
213.08
1 year 141.82
Extreme 141.8201
213.08
3 years 141.82
Extreme 141.8201
287.32
5 years 141.82
Extreme 141.8201
287.32
10 years 141.82
Extreme 141.8201
287.32
Manager TitleAgeSince
Chief Executive Officer 53 27/01/2020
Director of Finance/CFO 44 04/12/2025
Compliance Officer - 31/01/2023
Director TitleAgeSince
Director/Board Member 75 23/09/2002
Director/Board Member 71 25/07/2010
Chairman 53 27/04/2021
Date Insider Type Main position Quantity % Market Cap.
05-31Free

Executive/Senior Manager

14,258 0.0052%
05-31Other

Executive/Senior Manager

0 0%
05-31Fiscal year

Chief Executive Officer

60,627 0.0220%
Change 5d. change 1-year change 3-years change Capi.($)
-1.08%+2.61%-13.55%-40.23% 41.65B
-0.46%+3.61%-31.82%-9.75% 159B
-1.75%+8.45%-8.26%-3.45% 105B
-4.02%-4.39%+51.29%+48.31% 55.03B
-0.07%+3.84%-3.20%+55.78% 53.51B
-0.22%-5.93% - - 28.42B
+6.05%+4.65%-8.56%-35.32% 28.11B
+1.01%+0.31%+41.78%-9.29% 22.22B
+0.20%-2.60%-12.54%+5.08% 20.99B
-0.57%-0.63%-13.58%+1.72% 20.73B
Average -0.06%+0.21%+0.17%+1.43% 53.41B
Weighted average by Cap. -0.61%+3.33%-7.28%+1.98%

Financials

2026 *2027 *
Net sales 19.21B 16.63B 15.26B 14.36B 26.74B 1,830B 27.16B 181B 70.6B 885B 72.11B 70.54B 3,078B 19.72B 17.07B 15.67B 14.74B 27.45B 1,879B 27.88B 186B 72.47B 909B 74.03B 72.42B 3,160B
Net income 1.12B 974M 894M 841M 1.57B 107B 1.59B 10.62B 4.13B 51.83B 4.22B 4.13B 180B 1.46B 1.27B 1.16B 1.09B 2.04B 139B 2.07B 13.8B 5.37B 67.36B 5.49B 5.37B 234B
Net Debt 15.95B 13.82B 12.68B 11.93B 22.22B 1,520B 22.56B 151B 58.65B 735B 59.91B 58.6B 2,557B 14.07B 12.19B 11.18B 10.52B 19.59B 1,341B 19.9B 133B 51.73B 649B 52.84B 51.69B 2,255B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
08/06/26 149.68 $ -0.98% 285,159
05/06/26 151.16 $ +1.07% 2,077,544
04/06/26 149.56 $ +2.71% 2,241,684
03/06/26 145.61 $ +0.82% 1,609,724
02/06/26 144.43 $ -0.62% 2,693,516
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
151.16USD
Average target price
181.23USD
Spread / Average Target
+19.89%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
BENEFIT NOW